MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
63.2 M |
Market Cap[1] |
$ 789 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Spero Therapeutics
SPRO
|
$ 1.01 | -5.61 % | $ 56.6 M | Nasdaq Global Select Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 16.4 | -5.54 % | $ 1.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 73.9 | 4.32 % | $ 3.09 B | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.83 | -0.01 % | $ 11.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE |  Israel |
 |
Cabaletta Bio
CABA
|
$ 1.43 | -5.0 % | $ 144 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 4.12 | -8.35 % | $ 35.1 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 11.55 | 4.52 % | $ 1.61 B | Nasdaq Global Select Market |  France |
 |
Gilead Sciences
GILD
|
$ 170.68 | 0.8 % | $ 212 B | Nasdaq Global Select Market,SPB | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.28 | -2.06 % | $ 1.37 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
Gossamer Bio
GOSS
|
$ 11.2 | 5.21 % | $ 2.56 B | Nasdaq Global Select Market,SPB | USA |
 |
GeoVax Labs
GOVX
|
$ 0.11 | -22.17 % | $ 105 K | Nasdaq Global Select Market | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 588.33 | 1.01 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Vericel Corporation
VCEL
|
$ 59.02 | 1.08 % | $ 2.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 24.05 | -7.21 % | $ 1.89 B | Nasdaq Global Market,SPB | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 51.25 | -0.56 % | $ 208 B | NYSE |  Britain |
 |
Vir Biotechnology
VIR
|
$ 13.17 | -3.48 % | $ 1.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 28.67 | -1.1 % | $ 3.23 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.07 | -0.49 % | $ 240 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.55 | -1.11 % | $ 37.8 M | Nasdaq Global Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 547.74 | -0.57 % | $ 140 B | Nasdaq Global Select Market,SPB | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 20.88 | -1.42 % | $ 83.8 M | Nasdaq Global Select Market | USA |
 |
CNS Pharmaceuticals
CNSP
|
$ 3.81 | -3.3 % | $ 1.69 M | Nasdaq Capital Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 1.82 | -8.54 % | $ 107 M | Nasdaq Global Select Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.41 | -2.01 % | $ 575 M | Nasdaq Global Select Market | Singapore |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
Exicure
XCUR
|
$ 1.08 | 21.31 % | $ 6.8 M | Nasdaq Capital Market | USA |
 |
Immunome
IMNM
|
$ 18.65 | -3.67 % | $ 1.63 B | Nasdaq Global Select Market | USA |
 |
Xeris Pharmaceuticals
XERS
|
$ 15.81 | -0.35 % | $ 2.54 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 3.24 | -2.7 % | $ 137 M | Nasdaq Capital Market | USA |
 |
Xencor
XNCR
|
$ 39.42 | 2.16 % | $ 2.93 B | Nasdaq Global Select Market,SPB | USA |
 |
INmune Bio
INMB
|
$ 1.09 | -3.54 % | $ 27 M | Nasdaq Capital Market | USA |
 |
Insmed Incorporated
INSM
|
$ 119.55 | 2.97 % | $ 23.8 B | Nasdaq Global Select Market | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 28.02 | -9.63 % | $ 4.48 B | Nasdaq Global Select Market,SPB | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.21 | -7.63 % | $ 81.4 M | Nasdaq Global Select Market |  Germany |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.